SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation
CRSP 56.68-2.4%Dec 12 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Biomaven who started this subject6/10/2001 1:35:53 AM
From: Doc Bones  Read Replies (1) of 52153
 
A post from a 'trading' thread gives a list of stocks that have made higher highs and higher lows in May and June:

Message 15919835

Only 3 of the 16 stocks are not biotech:

CY = Cypress Semiconductor
TSEM = Tower Semiconductor
MXIM = Maxim Integrated Products

[I haven't verified the data]

Zeev Hed, a seemingly sharp but mostly technical analysis guru, replies:

Message 15920398

Now you see why I have been saying that the biotech may be much better vehicles over the next few months.

Zeev

********

Also:

1) One of the stocks is BBH, which is an exchange traded biotech fund. I think they have dropped a few of their stranger stocks, and are now a fairly good biotech representative. I prefer IBB, which tracks the NBI index, but the biggest problem with both is that they heavily emphasize AMGN and other big caps.

2) I remember that CY, Cypress Semiconductor, was a Gilder pick. It's a pretty mundane chipmaker to be found in anyones "cosm." I suspect that Gilder, who is aggressively right-wing Libertarian, picked it because the CEO, T.J. Rodgers, is outspoken on that subject also.

I hope the new Gilder biotech analyst, Dr. Scott Gottlieb, of the diatribe of many colors:

Message 15918107

was not chosen for ideological reasons.

Not that I don't agree with some of what he says. But I think some wind was taken out of the sails of the "Help, they're drugging our children" movement by the study of ADD, which showed that while one-third of ADD-diagnosed children taking ritalin went on to abuse other substances, two-thirds of the untreated ones did.

I'll try to keep an open mind on Gilder, but he has lost a lot of credibility, and subscribers, with picks like TERN and XLA. Not just the huge crashes, but XLA is not a stock any respectable person would want to be associated with.

Doc
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext